These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27931579)

  • 61. Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?
    Khandoga A; Drefs M; Schoenberg M; Schiergens T; Frenes K; Op den Winkel M; Trumm C; Angele MK; Guba M; Werner J; Rentsch M
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1045-1053. PubMed ID: 28562395
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure?
    De Carlis L; Di Sandro S; Giacomoni A; Mangoni I; Lauterio A; Mihaylov P; Cusumano C; Rampoldi A
    J Clin Gastroenterol; 2013 Apr; 47(4):352-8. PubMed ID: 23188072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis.
    Majno PE; Sarasin FP; Mentha G; Hadengue A
    Hepatology; 2000 Apr; 31(4):899-906. PubMed ID: 10733546
    [TBL] [Abstract][Full Text] [Related]  

  • 64. When Should We Propose Liver Transplant After Resection of Hepatocellular Carcinoma? A Comparison of Salvage and De Principe Strategies.
    Tribillon E; Barbier L; Goumard C; Irtan S; Perdigao-Cotta F; Durand F; Paradis V; Belghiti J; Scatton O; Soubrane O
    J Gastrointest Surg; 2016 Jan; 20(1):66-76; discussion 76. PubMed ID: 26582597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.
    Zheng Z; Liang W; Milgrom DP; Zheng Z; Schroder PM; Kong NS; Yang C; Guo Z; He X
    Transplantation; 2014 Jan; 97(2):227-34. PubMed ID: 24142034
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Choi SB; Kim HJ; Song TJ; Ahn HS; Choi SY
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):639-47. PubMed ID: 24867654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK; Kim DG; Moon IS; Lee MD; Park JH
    J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan.
    Ali MA; Li WF; Wang JH; Lin CC; Chen YJ; Lin TL; Lin TS; Lu SN; Wang CC; Chen CL
    HPB (Oxford); 2016 Oct; 18(10):851-860. PubMed ID: 27567971
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
    Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
    Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis.
    Zhang ZH; Li LX; Li P; Lv SC; Pan B; He Q
    J Invest Surg; 2019 Nov; 32(7):632-641. PubMed ID: 29557691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.
    de'Angelis N; Landi F; Carra MC; Azoulay D
    World J Gastroenterol; 2015 Oct; 21(39):11185-98. PubMed ID: 26494973
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Huang X; Lu S
    Scand J Gastroenterol; 2017 Feb; 52(2):143-149. PubMed ID: 27623157
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Liver transplantation for hepatocellular carcinoma--is there a risk of recurrence caused by intraoperative blood salvage autotransfusion?
    Foltys D; Zimmermann T; Heise M; Kaths M; Lautem A; Wisser G; Weiler N; Hoppe-Lotichius M; Hansen T; Otto G
    Eur Surg Res; 2011; 47(3):182-7. PubMed ID: 21986299
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W; Wang D; Ling X; Kao AA; Kong Y; Shang Y; Guo Z; He X
    Liver Transpl; 2012 Jan; 18(1):62-9. PubMed ID: 21964956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Living donor liver transplantation for recurrent hepatocellular carcinoma after liver resection.
    Kaido T; Mori A; Ogura Y; Hata K; Yoshizawa A; Iida T; Yagi S; Uemoto S
    Surgery; 2012 Jan; 151(1):55-60. PubMed ID: 21943635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.